H. Lundbeck A/S

Tweet this page
<
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 10 Jan 2024
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 17547932636-11

Overview

Lobbying Costs

25,000€ - 49,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

0.25 Fte (1)

Lobbyists with EP accreditation

0

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    H. Lundbeck A/S   (HLU)

    EU Transparency Register

    118500617129-29 First registered on 27 Apr 2015

    Goals / Remit

    H. Lundbeck A/S is a global pharmaceutical company specialized in brain diseases. For more than 70 years, we have been at the forefront of neuroscience research. We are tirelessly dedicated to restoring brain health, so every person can be their best.
    An estimated 700 million people worldwide are living with brain diseases and far too many suffer due to inadequate treatment, discrimination, a reduced number of working days, early retirement and other unnecessary consequences. Every day, we strive for improved treatment and a better life for people living with brain diseases – we call this Progress in Mind.
    Read more at www.lundbeck.com/global/about-us/progress-in-mind.
    Our approximately 5,000 employees in more than 50 countries are engaged in the entire value chain throughout research, development, production, marketing and sales. Our pipeline consists of several late-stage development programs and our products are available in more than 100 countries. Our research center is (...)

    Main EU files targeted

    Initiatives relevant for the pharmaceutical industry with the specific focus on brain health, mental health and neurology
    EU pharma legislation

    Address

    Head Office
    Ottiliavej 9
    Valby 2500
    DENMARK
    EU Office
    Ottiliavej 9
    Valby 2500
    DENMARK

    Website

  • People

    Total lobbyists declared

    1

    Employment timeLobbyists
    25%1

    Lobbyists (Full time equivalent)

    0.25

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    EFPIA - European Federation of Pharmaceutical Industries and Associations
    http://www.efpia.eu/

    DI - Confederation of Danish Industry
    http://di.dk/English/Pages/English.aspx

    LIF - Danish Association of the Pharmaceutical Industry
    https://www.lif.dk/

    EBC- European Brain Council
    http://www.europeanbraincouncil.org/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    25,000€ - 49,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    25,000€ - 49,999€

    Other financial info

    -

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Meeting with EVP EU Commissioner Margrethe Vestager, 12 September 2022

    Other activities

    Legislation and public policy areas relevant for the pharmaceutical industry and Lundbeck's focus within psychiatric and neurological disorders, eg. mental health

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    • Date 12 Sep 2022 Location Copenhagen
      Subject Green and digital transition and Pharma strategy.
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Christina Holm Eiberg (Cabinet member)
      • Margrethe Vestager (Executive Vice-President)
    • Date 21 May 2021 Location Copenhagen
      Subject Industrial Strategy
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Margrethe Vestager (Executive Vice-President)
      Other Lobbyists
Download this datacard